DGK-ε Antibodies

Santa Cruz Biotechnology provides a broad selection of DGK-ε monoclonal antibodies for research focused on diacylglycerol kinase epsilon. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DGK-ε plays a critical role in lipid signaling pathways by converting diacylglycerol into phosphatidic acid, thereby regulating cellular processes such as proliferation, differentiation, and apoptosis. The involvement of DGK-ε in various physiological and pathological conditions, including cancer and cardiovascular diseases, highlights its significance as a target for therapeutic interventions. Understanding DGK-ε function and regulation provides crucial insights into cellular signaling mechanisms. Researchers can explore the molecular interactions and cellular distribution of DGK-ε through multiple experimental approaches. Advanced research techniques enable detailed analysis of DGK-ε activity in different cellular environments. The high specificity of Santa Cruz Biotechnology monoclonal antibodies supports researchers worldwide in advancing scientific understanding of DGK-ε and its role in human health and disease.